GlassScriptPhysician profile
Janice B Dort
NPI 1700960648
$1,668.20
in general payments reported to CMS, 2019-2025
8 companies · $55.52 in 2025
The $55.52 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $98.27 · 2022: $482 · 2023: $703 · 2024: $329 · 2025: $55.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,088.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,088.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $678.25 | 2022-2024 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $341.95 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $323.93 | 2021-2023 | |
| Novo Nordisk INC | $125.00 | 2022 | |
| Idorsia Pharmaceuticals US INC | $124.43 | 2023 | Quviviq |
| Axsome Therapeutics, INC. | $35.00 | 2025 | Auvelity |
| Lilly USA, LLC | $20.52 | 2025 | Mounjaro, Zepbound |
| Abbott Laboratories | $19.12 | 2023 | Freestyle Libre 2 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janice Dort listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.